NantiBody Overview

  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1

NantiBody General Information

Description

Provider of treatment services of cancer and auto-immune diseases. The company develops immuno-oncology monoclonal antibodies, antibody drug conjugates, bispecific antibodies and immunotherapies for the treatment of cancer and associated pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NantiBody Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NantiBody‘s full profile, request access.

Request a free trial

NantiBody Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NantiBody‘s full profile, request access.

Request a free trial